OCI N.V. (LON:0QGH)
2.901
-0.035 (-1.19%)
At close: Dec 16, 2025
OCI N.V. Revenue
OCI N.V. had revenue of $283.45M USD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $1.03B, up 136.76% year-over-year. In the year 2024, OCI N.V. had annual revenue of $975.10M with 3.00% growth.
Revenue (ttm)
$1.03B
Revenue Growth
+136.76%
P/S Ratio
0.71
Revenue / Employee
$946.84K
Employees
1,091
Market Cap
537.17M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 975.10M | 28.40M | 3.00% |
| Dec 31, 2023 | 946.70M | -2.77B | -74.51% |
| Dec 31, 2022 | 3.71B | -2.61B | -41.23% |
| Dec 31, 2021 | 6.32B | 2.84B | 81.88% |
| Dec 31, 2020 | 3.47B | 442.40M | 14.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |